Divi's Laboratories logo

Divi's Laboratories results

NSE: DIVISLABBSE: 532488Pharmaceuticals & BiotechnologyLarge Cap

Last close ₹8,950.00down ₹212.00 (2.31%)BSE ₹8,984.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹9,162.00.

52-week range of traded prices to 23 Oct 2026
₹5,647.50Low, 2 Apr 2026₹9,740.00High, 24 Sep 2026
Market cap
₹2,37,594 Cr50th largest listed
P/E
81.2
P/B
14.2
Dividend yield
0.34%
ROE
18.4%
ROCE
20.8%
Debt to equity
0.00
Volume, NSE
6,20,26160.6% delivered

Q1 results, quarter to Jun 2026

Consolidated: the company and its subsidiaries together. ₹ crore.Divi's Laboratories annual results and balance sheet

Revenue
₹3,080 Cr+27.8% on a year ago · +8.8% on the quarter before
Operating profit
₹1,255 Cr+72.2% on a year ago · +34.4% on the quarter before
Net profit
₹902 Cr+65.5% on a year ago · +20.1% on the quarter before
Earnings per share
₹33.95+65.7% on a year ago · +19.9% on the quarter before
Operating margin
40.7%
Net margin
29.3%

From revenue to net profit, ₹ crore

  1. Revenue3,080
  2. Materials and goods−986
  3. Employee costs−408
  4. Other expenses−431
  5. Operating profit1,255
  6. Depreciation−133
  7. Other income+64
  8. Finance costs−6.0
  9. Profit before tax1,180
  10. Tax−278
  11. Net profit902

Divi's Laboratories results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2021Q2Filed 6 NovDec 2021Q3Filed 11 FebMar 2022Q4Filed 23 MayJun 2022Q1Filed 13 AugSep 2022Q2Filed 9 NovDec 2022Q3Filed 3 FebMar 2023Q4Filed 22 MayJun 2023Q1Filed 14 AugSep 2023Q2Filed 7 NovDec 2023Q3Filed 10 FebMar 2024Q4Filed 27 MayJun 2024Q1Filed 5 AugSep 2024Q2Filed 9 NovDec 2024Q3Filed 3 FebMar 2025Q4Filed 12 JunJun 2025Q1Filed 6 AugSep 2025Q2Filed 7 NovDec 2025Q3Filed 11 FebMar 2026Q4Filed 27 MayJun 2026Q1Filed 1 Aug
Revenue from operations1,9882,4932,5182,2551,8551,7081,9511,7781,9091,8552,3032,1182,3382,3192,5852,4102,7152,6042,8313,080
1,1691,3961,4141,4081,2341,2991,4631,2741,4301,3661,5721,4961,6221,5761,6991,6811,8271,7141,8971,825
Materials and goods bought6558328398126757408286888107299028539699229819561,0739451,119986
Employee costs224245257246232239258263266268297292304297350340354367381408
Other expenses291320319349327321378323354369373351349357368385400402397431
Operating profit before depreciation8181,0971,1048476214084885044794897316227167438867298888909341,255
Operating margin41.2%44.0%43.9%37.6%33.5%23.9%25.0%28.3%25.1%26.4%31.7%29.4%30.6%32.0%34.3%30.2%32.7%34.2%33.0%40.7%
Depreciation and amortisation7780818486878793959595979999107112113118120133
Other income191752888011466818695797910682861191458815564
Finance costs00000000102010138666
Profit before one-off items and tax7601,0341,0768516154364664924694897136047227268647339128549631,180
One-off items00000000000000000−7400
Profit before tax7601,0341,0768516154364664924694897136047227268647339127809631,180
153131181149122129146136121131175174212137202188223197212278
Tax rate20.2%12.7%16.8%17.5%19.8%29.6%31.2%27.6%25.8%26.8%24.5%28.8%29.4%18.9%23.4%25.6%24.5%25.3%22.0%23.6%
606902895702494307321356348358538430510589662545689583751902
Other comprehensive income0114331115−711103316−12
Total comprehensive income607903896706497310322357349363531431511590662548692599750904
Net margin30.5%36.2%35.5%31.1%26.6%18.0%16.5%20.0%18.2%19.3%23.4%20.3%21.8%25.4%25.6%22.6%25.4%22.4%26.5%29.3%
Earnings per share₹22.84₹33.99₹33.70₹26.44₹18.60₹11.56₹12.09₹13.41₹13.11₹13.50₹20.25₹16.20₹19.20₹22.20₹24.93₹20.49₹25.97₹21.98₹28.31₹33.95
Earnings per share in rupees, restated for later splits and bonuses.

Filed results, as an XML file each

16 earlier filings